UiPath's competitive edge lies in its AI integration, SAP partnership and industry-agnostic automation solutions, making it a strong contender in RPA despite generative AI threats. Recent struggles ...

UiPath (PATH) has been resilient in the face of potential disruption from generative AI. At this point, it is fairly clear that the company isn’t a gen AI winner, but the business is looking rather ...

UiPath Inc. today announced a preview of its upcoming Agent Builder tool as it outlined its vision to combine its expertise in robotic process automation with generative artificial intelligence models ...

UiPath is moving beyond simple, rule-based bots toward "agentic automation." Partnerships are helping to drive scalability of this evolving business. UiPath’s focus on security and transparency could ...

UiPath Inc. (NYSE:PATH) is one of the best mid cap AI stocks to buy right now. UiPath Inc. (NYSE:PATH) is one of the best midcap AI stocks to buy right now. On August 1, 2025, UiPath announced the ...

UiPath has a huge opportunity in front of it, and it's trading at a low valuation.

C3.ai, Inc. AI and UiPath Inc. PATH are both high-profile players in the booming AI automation sector. C3.ai specializes in enterprise AI applications, including predictive maintenance and generative ...

UiPath launches AI-based Medical Record Summarization tool, reducing processing time from 45 minutes to minutes. Powered by Google Cloud, the agent improves accuracy, saves 40 minutes per referral, ...

BigBear.ai is struggling to grow its core business. UiPath’s high-growth days are over, but the RPA market is still expanding. One of these niche AI stocks is clearly a better buy. BigBear.ai develops ...